Anna Saborowski

Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

Laura Izquierdo‐Sánchez, Ángela Lamarca, Adelaida La Casta et al. · Journal of Hepatology · 2022 · 343 citations · Full text

Medicine, Oncology, Pathology +14

Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors

Piro Lito, Anna Saborowski, Jingyin Yue et al. · Cancer Cell · 2014 · 312 citations · Full text

Medicine, Cancer Biology, Oncology +14

Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma

Gajanan Kendre, Karthikeyan Murugesan, Tilman Brummer et al. · Journal of Hepatology · 2022 · 162 citations · Full text

Medicine, Genetics, Oncology +17

Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins

Monika A. Davare, Anna Saborowski, Christopher A. Eide et al. · Proceedings of the National Academy of Sciences · 2013 · 117 citations · Full text

Medicine, Oncology, Pharmacology +17

Dual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development

Jessica Endig, Laura Elisa Buitrago‐Molina, Silke Marhenke et al. · Cancer Cell · 2016 · 83 citations · Full text

Medicine, Immunology, Oncology +17